Insider Transactions in Q4 2024 at Zentalis Pharmaceuticals, Inc. (ZNTL)

ZNTL Quotes by TradingView

Insider Transaction List (Q4 2024)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Nov 13 2024
Scott Dunseth Myers Director
BUY
Grant, award, or other acquisition
Direct
260,192 +50.0%
-
Oct 04 2024
Vincent Vultaggio Principal Accounting Officer
SELL
Open market or private sale
Direct
1,603 -4.52%
$4,809 $3.18 P/Share

Track Institutional and Insider Activities on ZNTL

Follow Zentalis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZNTL shares.

Notify only if

Insider Trading

Get notified when an Zentalis Pharmaceuticals, Inc. insider buys or sells ZNTL shares.

Notify only if

News

Receive news related to Zentalis Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ZNTL